SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-301621
Filing Date
2017-10-03
Accepted
2017-10-03 08:51:05
Documents
3
Period of Report
2017-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d377146d8k.htm 8-K 28389
2 EX-2.1 d377146dex21.htm EX-2.1 394918
3 EX-99.1 d377146dex991.htm EX-99.1 19859
  Complete submission text file 0001193125-17-301621.txt   444251
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 171116184
SIC: 2834 Pharmaceutical Preparations